Terms: = Ovarian cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Prognosis
11 results:
1. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the jak2/STAT3 pathway and interacting with ESM1.
Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J
J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795
[TBL] [Abstract] [Full Text] [Related]
2. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
3. Effects of Vitexin, a Natural Flavonoid Glycoside, on the Proliferation, Invasion, and Apoptosis of Human U251 Glioblastoma Cells.
Huang J; Zhou Y; Zhong X; Su F; Xu L
Oxid Med Cell Longev; 2022; 2022():3129155. PubMed ID: 35281458
[TBL] [Abstract] [Full Text] [Related]
4. ALKBH5-HOXA10 loop-mediated jak2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer.
Nie S; Zhang L; Liu J; Wan Y; Jiang Y; Yang J; Sun R; Ma X; Sun G; Meng H; Xu M; Cheng W
J Exp Clin Cancer Res; 2021 Sep; 40(1):284. PubMed ID: 34496932
[TBL] [Abstract] [Full Text] [Related]
5. SENP1-mediated deSUMOylation of jak2 regulates its kinase activity and platinum drug resistance.
Li J; Wu R; Yung MMH; Sun J; Li Z; Yang H; Zhang Y; Liu SS; Cheung ANY; Ngan HYS; Braisted JC; Zheng W; Wei H; Gao Y; Nemes P; Pei H; Chan DW; Li Y; Zhu W
Cell Death Dis; 2021 Apr; 12(4):341. PubMed ID: 33795649
[TBL] [Abstract] [Full Text] [Related]
6. Triptolide inhibits jak2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
Zhong Y; Le F; Cheng J; Luo C; Zhang X; Wu X; Xu F; Zuo Q; Tan B
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760192
[TBL] [Abstract] [Full Text] [Related]
7. [High Expression Level of SP1, CSF1R, and PAK1 Correlates with Sensitivity of Leukemia Cells to the Antibiotic Mithramycin].
Vagapova ER; Lebedev TD; Tikhonova AD; Goikhman BV; Ivanenko KA; Spirin PV; Prassolov VS
Mol Biol (Mosk); 2020; 54(3):522-528. PubMed ID: 32492016
[TBL] [Abstract] [Full Text] [Related]
8. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.
Liu HP; Zhang Y; Liu ZT; Qi H; Zheng XM; Qi LH; Wang JY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9286-9294. PubMed ID: 31773696
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of jak2/STAT3 and activation of caspase‑9/3 are involved in KYS05090S‑induced apoptosis in ovarian cancer cells.
Kim BI; Kim JH; Sim DY; Nam M; Jung JH; Shim B; Lee J; Kim SH
Int J Oncol; 2019 Jul; 55(1):203-210. PubMed ID: 31059018
[TBL] [Abstract] [Full Text] [Related]
10. Autocrine activation of jak2 by IL-11 promotes platinum drug resistance.
Zhou W; Sun W; Yung MMH; Dai S; Cai Y; Chen CW; Meng Y; Lee JB; Braisted JC; Xu Y; Southall NT; Shinn P; Huang X; Song Z; Chen X; Kai Y; Cai X; Li Z; Hao Q; Cheung ANY; Ngan HYS; Liu SS; Barak S; Hao J; Dai Z; Tzatsos A; Peng W; Pei H; Han Z; Chan DW; Zheng W; Zhu W
Oncogene; 2018 Jul; 37(29):3981-3997. PubMed ID: 29662190
[TBL] [Abstract] [Full Text] [Related]
11. DIMming ovarian cancer growth.
Kandala PK; Srivastava SK
Curr Drug Targets; 2012 Dec; 13(14):1869-75. PubMed ID: 23140296
[TBL] [Abstract] [Full Text] [Related]